Bio-Techne (TECH) Gross Profit (2009 - 2026)
Bio-Techne (TECH) recorded quarterly Gross Profit of $208.3 million in Q1 2026, up 8.89% quarter-over-quarter from $191.3 million in Q4 2025, and down 2.92% on a YoY basis from $214.6 million in Q1 2025.
Bio-Techne (TECH) Gross Profit (2009 - 2026) Analysis & Trends
Bio-Techne's Gross Profit history runs 18 years deep, the most recent figure standing at $208.3 million for Q1 2026.
- In Q1 2026, Gross Profit fell 2.92% year-over-year to $208.3 million; the TTM figure through Mar 2026 stood at $786.5 million (down 1.05% YoY), while the FY2025 annual figure was $790.3 million, up 2.67% from the prior year.
- Gross Profit was $208.3 million for Q1 2026 at Bio-Techne, up from $191.3 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $214.6 million in Q1 2025 to a low of $176.6 million in Q4 2023.
- Historically, Gross Profit has averaged $195.3 million across 5 years, with a median of $198.8 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Gross Profit climbed 19.72% in 2022, then dropped 3.69% in 2023.
- A 5-year view of Gross Profit shows it stood at $183.4 million in 2022, then fell by 3.69% to $176.6 million in 2023, then increased by 9.8% to $193.9 million in 2024, then declined by 1.35% to $191.3 million in 2025, then climbed by 8.89% to $208.3 million in 2026.
- The last three Gross Profit figures came in at $208.3 million (Q1 2026), $191.3 million (Q4 2025), and $188.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 208.29 Mn |
| Mar 31, 2026 | 208.29 Mn |
| Dec 31, 2025 | 191.28 Mn |
| Dec 31, 2025 | 191.28 Mn |
| Sep 30, 2025 | 188.11 Mn |
| Sep 30, 2025 | 188.11 Mn |
| Jun 30, 2025 | 198.81 Mn |
| Jun 30, 2025 | 198.81 Mn |
| Mar 31, 2025 | 214.56 Mn |
| Mar 31, 2025 | 214.56 Mn |
| Dec 31, 2024 | 193.89 Mn |
| Dec 31, 2024 | 193.89 Mn |
| Sep 30, 2024 | 183.02 Mn |
| Sep 30, 2024 | 183.02 Mn |
| Jun 30, 2024 | 203.35 Mn |
| Jun 30, 2024 | 203.35 Mn |
| Mar 31, 2024 | 204.60 Mn |
| Mar 31, 2024 | 204.60 Mn |
| Dec 31, 2023 | 176.59 Mn |
| Dec 31, 2023 | 176.59 Mn |